Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

IMPACT OF EARLY ART ON CD8 T CELLS IN MESENTERIC LYMPH NODES DURING SIV INFECTION

By Jimmy He PharmD, DScApril 28, 2020

CD8 T-cells play a pivotal role in clearance of HIV-infected cells, such that CD8 exhaustion contributes to their dysfunction and consequently, viral persistence. Mesenteric lymph nodes (MLNs), which drain the…

401 – Low Post-ART SIV Viral Load Set Point Associated With Enhanced Lymph Node CD8+ T-Cell Proliferation

By Jimmy He PharmD, DScMarch 20, 2025

…after analytic treatment interruption (ATI; range 65-225,000 c/mL). Methods To identify CD8+ T cell features that correlate with subsequent post-ATI pVL set point, we performed spectral flow cytometry including SIV-specific…

A QUANTITATIVE APPROACH TO EVALUATE ARV PROXIMITY TO VIRUS AND CELLS IN LYMPH NODES

By Enthusiast Inc MDMarch 7, 2019

…(N=6) in combination with either efavirenz (EFV) + raltegravir (RAL) (N=3), cohort FTER, or maraviroc (MVC) + atazanavir (ATZ) (N=3), cohort FTMA. Tissue accumulation of ARVs and metabolites was measured…

465 – Lymph Node Dendritic Cells Harbor an Altered Transcriptomic Profile Despite Years of Suppressive ART

By Jimmy He PharmD, DScApril 18, 2025

…the immune activation associated with HIV infection.  Methods We evaluated the influence of HIV infection on the functional and transcriptomic profile of lymph node (LN) myeloid dendritic cells (DCs) subsets during both chronic…

272 – scRNA-seq Maps NK-Like CD8 T- & NK-Cell Subsets in Lymph Nodes of ART-Treated SIV-Infected Macaques

By Jimmy He PharmD, DScMarch 31, 2026

Background In HIV/SIV infection, CD8 T and natural killer (NK) cells are critical antiviral effectors, yet the exact mechanisms for their inability to mediate durable viral control remains unclear and…

TELMISARTAN DOES NOT IMPROVE LYMPH NODE OR FAT FIBROSIS IN TREATED HIV INFECTION

By Enthusiast Inc MDFebruary 16, 2017

Chronic HIV infection is characterized by persistent inflammation and immune activation that can lead to tissue injury and fibrosis. Lymph node (LN) fibrosis may limit CD4+ T-cell recovery; LN and…

Increased Effector CD8 Lymphocyte Trafficking to Lymph Nodes Induced by hetIL-15

By Enthusiast Inc MDFebruary 16, 2016

…nodes expresses CXCR5, indicating ability to migrate into germinal centers where chronically infected CD4+Tfh reside. MCI confirmed the presence of effector CD8 cells in germinal centers and showed that these…

HIV DNA AND ACTIVATION DIFFER FOR LONG-LIVED CD4 CELLS IN LYMPH NODES AND PBMC ON ART

By Jimmy He PharmD, DScApril 4, 2022

…memory (CM), transitional memory (TM) and effector memory (EM). T cell subsets were sorted from 32 people with HIV on ART, including 11 with matched PBMCs and LN, 5 virologically…

TLR9 AGONIST ENHANCES B CELL DIFFERENTIATION AND ANTIBODY PRODUCTION IN HIV+ ADULTS

By Enthusiast Inc MDMarch 5, 2018

…observed increase in IgG plasma levels. In lymph nodes the increase in follicular and germinal center B cells point towards a restoration of lymph node architecture. Overall, these data suggest…

Our Voices

By Michelle ValderamaMarch 11, 2025

…impact that PEPFAR had on the disease when it arrived in the country in 2004. They discuss how PEPFAR has operated in Zambia and provide a current overview of the…

←1
234567891011121314151617181920212223242526
…2728293031…
323334353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top